Tonix Pharmaceuticals Holding Corp. (TNXP) vs Tenaya Therapeutics, Inc. (TNYA)

A side-by-side comparison of Tonix Pharmaceuticals Holding Corp. and Tenaya Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — TNXP vs TNYA

growth of $100 · dividends reinvested · last 5y
TNXP -100.0% (-88.1%/yr)TNYA -96.3% (-48.4%/yr)TNYA compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020222023202420252026$0$4
TNXP TNYA

TNXP vs TNYA: by the numbers

  • •TNXP is the larger company ($123M vs $119M market cap).
  • •Both run net losses; TNXP's is the smaller (-548.64% vs -7723.97% net margin).

Metrics side by side

Valuation

MetricTNXPTNYA
P/S ratio4.2188.83
P/B ratio0.551.71

Profitability

MetricTNXPTNYA
Gross margin34.65%0.00%
Operating margin-959.05%0.00%
Net margin-548.64%-7723.97%
ROE-71.83%-148.56%
ROIC-74.08%-142.06%

Growth (annualized)

MetricTNXPTNYA
Total return CAGR (5Y)-87.55%-52.81%

Frequently asked

How have TNXP and TNYA total returns compared?
Over the past 5 years, TNXP delivered -87.55% and TNYA delivered -52.81% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.